Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Comparison of vasopressors in mitigating secondary damage after traumatic spinal cord injury.
FY 2015-16
Summary
Acute traumatic spinal cord injuries (SCIs) are devastating events commonly resulting from motor vehicle accidents, falls, and sporting incidents. The damage arising from SCIs occurs in two stages: the primary injury is caused by themechanical impact itself, while the secondary injury is associated with processes such as inflammation, ischemia, excitotoxicity, oxidative stress, and apoptotic cell death. Since secondary injury develops in the hours and days following the initial trauma, this gives clinicians a window of opportunity in which to intervene and minimize injury progression. One common intervention strategy is vasopressor drug administration to improve bloodpressure, spinal cord blood flow (SCBF), oxygenation, and energy availability to cells in the injury penumbra.Currently, physicians can choose from several vasopressors, but this choice is often based on personal/institutional preference or drug availability, and not on established evidence-based protocols for which vasopressor is ideally suitedfor use post-SCI. Since different vasopressors have unique pharmacological properties and mechanisms of action, it is likelythat they also have differing effects on SCBF. In this grant I will investigate which of the two commonly used vasopressors – norepinephrine or phenylephrine – best restores SCBF, oxygenation, and metabolic function to the spinal cord after SCI. These parameters will be measured in our porcine model of SCI and will be confirmed with behavioural locomotion testing to see whether vasopressor administration affects functional ability.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
350007
Name
Gheorghe Ana-Stefania
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Comparison of vasopressors in mitigating secondary damage after traumatic spinal cord injury.
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Blood Flow; Hemodynamics; Oxygenation; Secondary Injury; Spinal Cord Injury; Vasopressor
Abstract
Acute traumatic spinal cord injuries (SCIs) are devastating events commonly resulting from motor vehicle accidents, falls, and sporting incidents. The damage arising from SCIs occurs in two stages: the primary injury is caused by themechanical impact itself, while the secondary injury is associated with processes such as inflammation, ischemia, excitotoxicity, oxidative stress, and apoptotic cell death.<span> <span>Since secondary injury develops in the hours and days following the initial trauma, this gives clinicians a window of opportunity in which to intervene and minimize injury progression. One common intervention strategy is vasopressor drug administration to improve bloodpressure, spinal cord blood flow (SCBF), oxygenation, and energy availability to cells in the injury penumbra.Currently, physicians can choose from several vasopressors, but this choice is often based on personal/institutional preference or drug availability, and not on established evidence-based protocols for which vasopressor is ideally suitedfor use post-SCI. Since different vasopressors have unique pharmacological properties and mechanisms of action, it is likelythat they also have differing effects on SCBF. <span>In this grant I will investigate which of the two commonly used vasopressors – norepinephrine or phenylephrine – best restores SCBF, oxygenation, and metabolic function to the spinal cord after SCI. These parameters will be measured in our porcine model of SCI and will be confirmed with behavioural locomotion testing to see whether vasopressor administration affects functional ability.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Gheorghe, Ana-Stefania
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~